• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Proscia

Spectrum Taps Proscia to Modernize its Pathology Operations

by Syed Hamza Sohail 03/13/2023 Leave a Comment

Spectrum Taps Proscia to to Modernize its Pathology Operations

- Proscia®, a leading provider of digital and computational pathology solutions, today announced that Spectrum Healthcare Partners (SHCP), an independent, multispecialty, physician-owned healthcare practice, has selected Concentriq® Dx to modernize its pathology operations. In adopting Proscia’s software platform, SHCP will increase access to high-quality diagnostic services across Maine and New Hampshire, better informing treatment decisions for more patients. - Digital pathology, which
Read More

PathGroup Expands Operations with Proscia Concentriq Dx

by Strategic Partnerships 03/01/2023 Leave a Comment

JPC Taps Proscia to Modernize World's Largest Human Tissue Repository

What You Should Know: - PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia's software platform (Concentriq® Dx) to further enhance the delivery of faster, higher quality results for millions of patients, helping to better inform treatment decisions. - PathGroup currently supports more than 15,000 referring physicians and over 200 hospital
Read More

Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023?

by Imogen Fitt, Market Analyst at Signify Research 02/03/2023 Leave a Comment

Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed?

News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. Their discussions centered around the progress of the market and its inevitable future developments.  Whilst our in-depth analysis of the implications of Fujifilm’s specific deal will be released soon as a part of our Premium Insights
Read More

Netherlands Cancer Institute to Deploy Proscia’s Pathology Platform

by Fred Pennic 01/18/2023 Leave a Comment

Netherlands Cancer Institute (NKI) to Deploy Proscia’s Pathology Platform To Drive Personalized Diagnosis

What You Should Know:  - Proscia®, a provider of digital and computational pathology solutions, announced that the Netherlands Cancer Institute (NKI), one of the top 10 comprehensive cancer centers in Europe, will deploy its Concentriq® Dx platform.  - NKI is transitioning to Concentriq Dx to expand its digital pathology practice, laying the foundation for its pathologists to deliver personalized diagnoses that better inform treatment decisions. In doing so, the cancer center,
Read More

Research: Proscia AI Predicts Diagnostic Agreement for Melanoma

by Syed Hamza Sohail 11/02/2022 Leave a Comment

JPC Taps Proscia to Modernize World's Largest Human Tissue Repository

What You Should Know: - Proscia® a provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer. - The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance. Findings
Read More

Proscia Unveils New Enhancements to its Digital Pathology Platform

by Syed Hamza Sohail 10/12/2022 Leave a Comment

Proscia Unveils New Enhancements to its Digital Pathology Platform

What You Should Know: - Proscia®, a leading provider of digital and computational pathology solutions, has introduced the next version of its Concentriq® Dx platform for primary diagnostic workflows, which is CE-marked under IVDR. - The release brings together new features and a compelling user experience to help even the largest laboratory networks transition to 100% digital diagnosis. In doing so, they can realize the full promise of the shift away from microscope-based
Read More

Proscia Raises $37M for AI-Enabled Pathology Platform

by Jasmine Pennic 06/14/2022 Leave a Comment

JPC Taps Proscia to Modernize World's Largest Human Tissue Repository

What You Should Know: - Proscia, a Philadelphia-based provider of digital and computational pathology solutions raises $37M to advance the way we understand and treat diseases like cancer. The round includes participation from Highline Capital Management, Triangle Peak Partners, and Alpha Intelligence Capital as well as existing investors including Scale Venture Partners, Hitachi Ventures, ROBO Global, Emerald Development Managers, and Razor's Edge Ventures. This investment brings Proscia's
Read More

Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration

by HIMSS22 Summary 03/16/2022 Leave a Comment

HIMSS22 Day 2 Roundup: Google Partners with MEDITECH, Microsoft’s Health Cloud Strategy Expansions,

Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More

Proscia and Siemens Healthineers Expands Global Reach of Digital Pathology

by Jasmine Pennic 03/16/2022 Leave a Comment

JPC Taps Proscia to Modernize World's Largest Human Tissue Repository

What You Should Know: - Proscia®, a digital and computational pathology solution announced a multi-year OEM agreement with Siemens Healthineers. - Under the agreement, Siemens Healthineers will enter the market by combining its Syngo Carbon enterprise imaging solution with Proscia’s Concentriq Dx digital pathology platform.
Read More

Proscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital Pathology

by Jasmine Pennic 03/09/2022 Leave a Comment

Proscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital Pathology

What You Should Know: - Proscia, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, today announced a collaboration to accelerate digital pathology adoption at an enterprise scale. - The cooperation agreement increases the availability of the companies' best-of-breed, unified solution that combines Proscia's Concentriq® platform and Hamamatsu's NanoZoomer® series of whole slide scanners to deliver
Read More

  • Go to page 1
  • Go to page 2
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |